Introducing the GenapSys™ Sequencer
Sequencing without compromise
The GenapSys™ Sequencer is exceptionally accurate, incredibly scalable, and amazingly affordable.
Introducing the GenapSys™ Sequencer
Innovative electrical detection enables accurate, scalable and affordable sequencing.
GenapSys has developed a novel electrical-based platform capable of accurately detecting single base incorporations. The semiconductor chip-based detection modality allows the system to be compact, scalable, and affordable.
DISCOVER OUR TECHNOLOGY
GenapSys technology achieves
>80% of bases >Q30
The GenapSys platform has been successfully demonstrated in a range of
applications that include targeted sequencing to elucidate
both germline and somatic mutations, as well as sequencing a range of small genomes.
The latest GenapSys news & upcoming events.
Redwood City, CA (Nov. 20, 2019) -- GenapSys Inc. announced today that it has completed a $90 million funding
round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate sequencer ever
developed.
Read more >
Despite single cell RNA technologies being front and center at the AGBT meeting in Marco Island, Florida, last week, two new DNA sequencing technology presentations from MGI and Genapsys created their own buzz. Both companies presented big plans in the sequencing space, but they are far too new on the scene to predict disruption of …
Read more >
Meet GenapSys at the Association of Biomolecular Resource Facilities
Read more >
